- Biofeedback-assisted pelvic floor muscle therapy (PFMT) improves symptoms and increases functional bladder capacity in children with drug-resistant overactive bladder (OAB).
- The therapy is effective in children with or without dysfunctional voiding with secondary bladder overactivity (DV/SBO).
Why this matters
- Antimuscarinics such as oxybutynin are a first-line treatment for OAB, but do not always work and can cause adverse effects that are more pronounced in children than in adults.
- Researchers analyzed the health records of children with drug-resistant OAB, either with or without DV/SBO, who were treated with PFMT (N=24; 66.6% boys; mean age, 8.1±2.0 years; age range, 6‐13 years).
- Funding: None disclosed.
- In patients with DV/SBO:
- Urgency was improved or cured in 6 of 7 (86%; P=.031).
- Maximum voided volume (maxVV) increased from 115.6 to 175.7 mL (P=.063).
- In patients without DV/SBO:
- Urgency was improved or cured in 12 of 17 (71%; P<.0001>
- MaxVV increased from 81.6 to 150.9 mL (P<.0001>
- The study was retrospective and had a small sample size; ethical considerations precluded establishing an untreated control group.